エノキシモン

Enoximone

HCID 53708CAS 77671-31-9

基本情報

標準SMILES
CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1
InChIKey
ZJKNESGOIKRXQY-UHFFFAOYSA-N
分子式
C12H12N2O2S
平均分子量
248.3 g/mol
単同位体質量
248.06194862

概要

Enoximone is an aromatic ketone.

名称と識別子

優先名称
Enoximone
IUPAC
4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one
現地名
エノキシモン
英語名
Enoximone
分子式
C12H12N2O2S
分子量
248.3

名称と別名

ENOXIMONE77671-31-9PerfanFenoximoneMDL-17043EnoximonumEnoximonaMDL 17,0434-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-oneDTXSID8045147C7Z4ITI7L74-Methyl-5-(p-(methylthio)benzoyl)-4-imidazolin-2-one
名称をさらに表示
1,3-ジヒドロ-4-メチル-5-[4-(メチルチオ)ベンゾイル]-2H-イミダゾール-2-オンエノキシモンペルファンフェノキシモン4-メチル-5-[4-(メチルスルファニル)ベンゾイル]-2,3-ジヒドロ-1H-イミダゾール-2-オンPedaneRMI-17043Enoximone USP/EP/BPEnoximone, 10 mM in DMSO4-Methyl-5-(4-(methylthio)benzoyl)-1H-imidazol-2(3H)-one1,3-DIHYDRO-4-METHYL-5-[4-METHYLTHIOBENZOYL]-2H-IMIDAZOL-2-ONE
DTXCID60251472H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-[4-(methylthio)benzoyl]-4-methyl-5-((4-(methylsulfanyl)phenyl)carbonyl)-2,3-dihydro-1H-imidazol-2-one4-methyl-5-{[4-(methylsulfanyl)phenyl]carbonyl}-2,3-dihydro-1H-imidazol-2-oneMDL17043MDL 17043MDL17,043

データベース識別子

CAS
77671-31-9
PubChem CID
53708
DTXSID
DTXSID8045147
ChEMBL
CHEMBL249856
ChEBI
CHEBI:135010
UNII
C7Z4ITI7L7
EC Number
989-259-7
Nikkaji
J22.780C

物性

構造計算による物性

XLogP
1.6
極性表面積
83.5 Ų
水素結合供与体数
2
水素結合受容体数
3
回転可能結合数
3
重原子数
17

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LogP1.55
Solubility6.82e-02 g/L
Melting Point256 °C
Physical DescriptionSolid

物理化学的性質

融点
255 · 255-258°C
比重(密度)
1.33 · 1.33
貯蔵温度
Sealed in dry,Room Temperature
溶解性
28 mg/mL、可溶 · DMSO: 28 mg/mL、可溶
酸解離定数(Pka)
10.37 · 10.37±0.70(Predicted)
外見
個体

安全と法規制

GHS分類

GHS ClassificationNot Classified

危険有害性情報

Other Safety InformationIMAP assessments - 2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)-: Environment tier I assessment
Hazard Classes and CategoriesNot Classified

安全データ

wgk
3
ridadr
3249
hazard_class
6.1(b)
packing_group
III
ストレージクラス
10 - Combustible liquids

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system

QC - Cardiovascular system

Protein Binding85%
Pharmacodynamics · 1 件

Enoximone is a phosphodiesterase inhibitor (type III) that increases the force of contraction of the heart and dilates blood vessels. In June 2005, Myogen announced that they were discontinuing development of enoximone due to negative results. The drug is approved for use in the UK.

Mechanism of Action · 1 件

Further research is required to determine accurately the mechanism of action of drugs with phosphodiesterase inhibitory activity, however, inhibition of PDE3 inhibits degredation of cGMP. This allows for increased NO release and vascular relaxation.

Biological Half-Life4-10 hours
Metabolism/MetabolitesHepatic oxidation

応用分野

説明Enoximone is a phosphodiesterase inhibitor indicated for selective use as a cardiostimulant in heart transplant patient maintenance. It is currently being investigated for other indications including acute congestive heart failure.

使用Enoximone is a phosphodiesterase inhibitor used in the treatment of congestive heart failure and is selective to phosphodiesterase 3. Potent PDE-3 inhibitor.

上流・下流製品情報

サプライヤー49 社

武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
北京索莱宝科技有限公司010-50973130 17801761073 · [email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]

関連反応

0 件

現在のフィルター条件では反応記録がありません。

関連ノート

読み込み中…